Post-earnings recap
Reported
Thu, May 8, 2025
EPS actual
$-0.09
EPS est.
$-0.04
EPS surprise
-109.30%
1-day move
+1.61%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Cytek Biosciences reported a loss per share of $0.09, significantly missing expectations. Despite this, the stock rose by 1.61%, indicating that investors may have reacted positively to other aspects of the report or are optimistic about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.09 | N/A | -109.30% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on the numerical results.